Showing results out of
Researchers discover how DNA mutations change blood cell production and how this relates to ageing and cancer development.
SCIENCE & TECHNOLOGY2022
research-highlightssciencescience-technology
The Gerstung Group at EMBL-EBI and collaborators have developed a statistical model that analyses genomic data to predict whether a patient has a high or low risk of developing oesophageal cancer.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Researchers have developed an artificial intelligence algorithm that uses computer vision to analyse tissue samples from cancer patients. The algorithm can distinguish between healthy and cancerous tissues, and can also identify patterns DNA and RNA changes in tumours.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
DNA mutations are caused by a combination of DNA damage and repair, shows study by EMBL-EBI and collaborators.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
EMBL co-leads most comprehensive study of genetic causes of cancer
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Researchers at EMBL’s European Bioinformatics Institute (EMBL-EBI) and the Francis Crick Institute have analysed the whole genomes of over 2600 tumours from 38 different cancer types to determine the chronology of genomic changes during cancer development.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Acute myloid leukaemia risk could be detected years before diagnosis
SCIENCE & TECHNOLOGY2018
sciencescience-technology
What worms can tell us about cancer
SCIENCE & TECHNOLOGY2018
sciencescience-technology
New group explores why patients with same cancer exhibit unique constellations of genetic mutations.
LAB MATTERSPEOPLE & PERSPECTIVES2015
lab-matterspeople-perspectives
No results found